Spark UVa,,cents 387 anti-human/mouse Granzyme B Recombinant [QA18A28]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471302
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $280.00
About this award
The University of Virginia awarded contract A207_PO-0471302 to BioLegend Inc. on August 20, 2026, for the procurement of specialized laboratory reagents. The contract value totals $280 and encompasses a single line item for one unit of Spark UVa anti-human/mouse Granzyme B Recombinant product (QA18A28), priced at $280 per unit. The deliverable is designated for Mary Grachus Harp at the University of Virginia in Virginia.
This purchase order represents a straightforward procurement of immunological research materials by a Virginia higher education institution. The contract documents do not specify an extended period of performance or annual value separate from the cumulative contract amount. BioLegend Inc. serves as the prime contractor for this life sciences supply award.
Line items
| Item | Total |
|---|---|
| Spark UVa,,cents 387 anti-human/mouse Granzyme B Recombinant [QA18A28] | $280.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471302?
Contract A207_PO-0471302 was awarded to BIOLEGEND INC. by University of Virginia on August 20, 2026.
How much is contract A207_PO-0471302 worth?
Its cumulative value is $280.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award